Chief Executive Officer, Co-Founder
Biotechnology
Taiga Biotechnologies
United States of America
Dr. Refaeli is an expert in the genetic manipulation of cells, regulation of gene expression and transformation in hematopoetic lineages. His research interests focus on three broad area: 1) the contribution of antigen receptor signaling to lymphoid neoplasica; 2) the role of role of proto-oncogenes in the regulation of lymphoid tolerance and disease; and 3) the role of MYC in the regulation of stem cell proliferation, survival, self-renewal and differentiation.
Medicine, biotechnology reserach work